Kyoto University, Japan

Email: [email protected]

1996 M.D., Kyoto University, Faculty of Medicine

Publications (Selected)

1. Masuo, Y., Yonekura, S., Nakajima, S., Sawada, Y., & Kabashima, K. (2025). Clinical factors predicting nemolizumab response in atopic dermatitis. Journal of Allergy and Clinical Immunology: Global, 4(2), 100457.
2. Mizukawa, Y., Hama, N., Niihara, H., Miyagawa, F., Hashizume, H., Tohyama, M., ... & Asada, H. (2025). Guidelines for the management of drug‐induced hypersensitivity syndrome 2023. The Journal of Dermatology, 52(3), e189-e209.
3. Chen, K. Y., De Giovanni, M., Xu, Y., An, J., Kirthivasan, N., Lu, E., ... & Cyster, J. G. (2025). Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes. Cell, 188(4), 1019-1035.
4. Sakiyama, T., Endo, Y., Nakamizo, S., & Kabashima, K. (2025). Elevation of serum carcinoembryonic antigen as a possible predictor of response to pulse methylprednisolone in acquired idiopathic generalized anhidrosis. Clinical and Experimental Dermatology, 50(1), 125-129.
5. Kita, Y., Nomura, T., Nakajima, S., Yonekura, S., Murakami, K., Sumiyoshi, T., ... & Kobayashi, T. (2024). Safety and Efficacy of Prophylactic Topical Steroid Administration for Enfortumab Vedotin–related Cutaneous Toxicity. European Urology Open Science, 70, 18-20.
6. Gooderham, M., Guttman-Yassky, E., Igawa, K., Kabashima, K., Esfandiari, E., Rylands, A. J., ... & Simpson, E. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. Dermatology and Therapy, 1-16.
7. Satoh, T., Murota, H., Aoyama, Y., Hashimoto, T., Ishiuji, Y., Hatano, Y., ... & Katayama, I. (2024). Prurigo chronica multiformis: Expert consensus of the Japanese Dermatological Association. The Journal of Dermatology, 51(11), e376-e383.
8. Sasai, T., Nakashima, R., Handa, T., Yamano, Y., Kondo, Y., Matsuda, S., ... & Morinobu, A. (2024). Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort study. Clinical Immunology, 268, 110372.
9. Kojima, M., Mieno, H., Ueta, M., Nakata, M., Teramukai, S., Sunaga, Y., ... & Sotozono, C. (2024). Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan. American Journal of Ophthalmology, 267, 50-60.
10. Kusumoto, Y., Ueda, M., Hashimoto, M., Takeuchi, H., Okada, N., Yamamoto, J., ... & Tomura, M. (2024). Sublingual immune cell clusters and dendritic cell distribution in the oral cavity. JCI insight, 9(21), e167373.
11. Brian, S. K., Ständer, S., Kabashima, K., Mohawk, J. A., Sherri, S. O., Goncalves, J., ... & Lebwohl, M. (2024). Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey. Acta Dermato-Venereologica, 104, 39941.
12. Nakajima, S., Nakamizo, S., Nomura, T., Ishida, Y., Sawada, Y., & Kabashima, K. (2024). Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions. Allergy, 79(9), 2366-2379.
13. Nakamizo, S., Doi, H., & Kabashima, K. (2024). Metabolic dynamics in psoriatic epidermis: enhanced glucose and lactate uptake, glycolytic pathway and TCA cycle dynamics. Experimental Dermatology, 33(7), e15127.
14. Nakamizo, S., & Kabashima, K. (2024). Metabolic reprogramming and macrophage polarization in granuloma formation. International Immunology, 36(7), 329-338.
15. Guttman‐Yassky, E., Kabashima, K., Staumont‐Salle, D., Nahm, W. K., Pauser, S., Da Rosa, J. C., ... & Reich, K. (2024). Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy, 79(6), 1560-1572.
16. Faye, O., Flohr, C., Kabashima, K., Ma, L., Paller, A. S., Rapelanoro, F. R., ... & Taïeb, A. (2024). Atopic dermatitis: A global health perspective. Journal of the European Academy of Dermatology and Venereology, 38(5), 801-811.
17. Nakaizumi, H., Kambe, N., Irie, H., Kaku, Y., Fujimoto, M., Yoshifuji, H., ... & Kabashima, K. (2024). Neutrophilic epitheliotropism, proposed as an auto‐inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases. The Journal of Dermatology, 51(4), 592-596.
18. Renert‐Yuval, Y., Del Duca, E., Arents, B., Bissonnette, R., Drucker, A. M., Flohr, C., ... & Thyssen, J. P. (2024). Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 38(1), 42-51.

Profile Details

WoS ResearcherID: G-2521-2014

https://www.med.kyoto-u.ac.jp/en/research/field/doctoral_course/r-039

https://scholar.google.com/citations?user=5uwXXKAAAAAJ&hl=en